Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-10-3573
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway

Cancer Research
Cancer ResearchOncology
2012English

FOXC1 Silencing Promotes A549 Cell Apoptosis Through Inhibiting the PI3K/AKT/hedgehog/Gli2 Signaling Pathway

RSC Advances
ChemistryChemical Engineering
2018English

FOXP1 Regulation via the PI3K/Akt/p70S6K Signaling Pathway in Breast Cancer Cells

Oncology Letters
Cancer ResearchOncology
2015English

CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway

Cancer Management and Research
Oncology
2019English

Resveratrol Attenuates Oxidative Stress-Induced Intestinal Barrier Injury Through PI3K/Akt-Mediated Nrf2 Signaling Pathway

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2019English

miR-19b Serves as a Prognostic Biomarker of Breast Cancer and Promotes Tumor Progression Through PI3K/AKT Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2018English

PIAS1 Regulates Breast Tumorigenesis Through Selective Epigenetic Gene Silencing

PLoS ONE
Multidisciplinary
2014English

Activation of Autophagy During Farnesyl Pyrophosphate Synthase Inhibition Is Mediated Through PI3K/AKT/mTOR Signaling

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Pristimerin Overcomes Adriamycin Resistance in Breast Cancer Cells Through Suppressing Akt Signaling

Oncology Letters
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy